Mr. Harrington is President, Chief Executive Officer and a Director of the VentureMed. Previously, he was the owner of Denis L Harrington Consulting, LLC a management and strategy consulting firm he established in December, 2012 after nearly 30 years of successful leadership roles in the US Army and the Medical Device Industry. Denis presently serves as an Executive Consultant and Board Director for several medical device companies. Denis has previously served as CEO for BridgePoint Medical and NexGen Medical, successfully leading BridgePoint from its development stage through commercialization and to successful acquisition by Boston Scientific in October, 2012. Denis came to BridgePoint Medical from Boston Scientific where he spent 18 years. Denis last role at BSC was as Senior Vice-President of US Cardiology, Rhythm and Vascular Sales – managing over 1800 people and $3 billion in revenue. Denis is a graduate of the United States Military Academy at West Point. He and his wife reside in Wayzata MN and have four grown sons, two daughters-in-law and two grandchildren.

Dr. Pigott is the founder and Chief Medical Officer of VentureMed. He is the past Director of endovascular surgery at the Jobst Vascular Institute and current Chief Innovation Officer for ProMedica Health Systems in Toledo, Ohio. Dr. Pigott previously completed a fellowship in vascular surgery at the Mayo Clinic and is involved with multiple product trainings with Boston Scientific, J&J, Cook, Abbott and Medtronic.  With more than seventy-five peer-reviewed publications, podium presentations, and book chapter authorship to his credit, he has spent more than twenty years in the endovascular arena.

Mr. Michaelson is the Vice President of sales at VentureMed.  He has more than thirty years of medical device sales, management and business development experience, where he has specialized in launching new technologies for Fortune 500 companies, as well as early stage startup companies.  Mr. Michaelson has more than twenty years in the cardiovascular field with SCIMED, Boston Scientific, Guidant, Medtronic, and Biotronik. Most recently, he held sales leadership roles at Osprey Medical and Zyga Technology where he built national and regional sales teams to execute growth strategies for innovative new medical devices. Mr. Michaelson received a BS in Business Administration with a major in Marketing from the University of Arizona.

Ms. Zeroni is the Vice President of R&D and Operations at VentureMed.  She brings 17 years of medical device research and development experience to the company, most recently as the Director of R&D and PMO at Stryker, leading the development and integration of ENT products. Ms. Zeroni has led R&D/Operations groups through successful integration and technology transfer including 510k and PMA devices (Fox Hallow to Covidien, CV Ingenuity to SPNC and Entellus to Stryker). Her background includes: building Operations teams from the ground up including successful launches of several devices in the vascular space with PTA and atherectomy devices (EV3/COV), Drug coated balloon (Spectranetics), drug coated Stents and other implants (Surmodics). Ms. Zeroni served in the Israeli Defense Forces and also received a BS in Chemical Engineering at Ben-Gurion University (Israel) and MS in Chemical Engineering from Ben-Gurion University (Israel) partnering with the Max Planck Institute (Germany).

Ms. Schweiger is the Vice President of clinical, regulatory, and quality assurance at VentureMed.  She has more than thirty years of experience in the medical device industry, with the majority of her career focused in venture capital-funded, early-stage medical device companies.  Most recently, Ms. Schweiger led execution of the global regulatory, QA, and clinical strategies at Medovex.  She previously held executive positions and responsibilities at Flowonix Medical, Angel Medical Systems, and several companies acquired by J&J, Teramed, IsoStent, and Gynecare.  She spent the early part of her career with Baxter Healthcare and Eli Lilly. Ms. Schweiger received a BS in Mechanical Engineering from Virginia Polytechnic Institute and State University (Virginia Tech).

Ms. Hautman is the Chief Financial Officer at VentureMed.  She brings nearly thirty years of financial experience in the medical device, insurance administration, and Venture Capital Industries.  Most recently, Ms. Hautman served as the Chief Financial Officer for Three Wire Inc., a patient recruitment firm. Prior to Three Wire, Inc., held Senior Finance and controller positions at Award Staffing, CoAxia, Raymedica, Inc., DRIASI, and Pathfinder Venture Capital Funds. She received a BS in Business, Accounting from the University of Minnesota, Carlson School of Management.